CN1872338A - Chewing tablet for discharging lead, and preparation method - Google Patents
Chewing tablet for discharging lead, and preparation method Download PDFInfo
- Publication number
- CN1872338A CN1872338A CNA2005100350190A CN200510035019A CN1872338A CN 1872338 A CN1872338 A CN 1872338A CN A2005100350190 A CNA2005100350190 A CN A2005100350190A CN 200510035019 A CN200510035019 A CN 200510035019A CN 1872338 A CN1872338 A CN 1872338A
- Authority
- CN
- China
- Prior art keywords
- chewing tablet
- zinc
- fine powder
- discharging lead
- granule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001055 chewing effect Effects 0.000 title claims abstract description 29
- 238000007599 discharging Methods 0.000 title claims description 28
- 238000002360 preparation method Methods 0.000 title description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000011701 zinc Substances 0.000 claims abstract description 19
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 18
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000003969 glutathione Nutrition 0.000 claims abstract description 17
- 229960003180 glutathione Drugs 0.000 claims abstract description 17
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 17
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 15
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 15
- 229960003080 taurine Drugs 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 11
- 230000008569 process Effects 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims description 43
- 239000008187 granular material Substances 0.000 claims description 25
- 241000283690 Bos taurus Species 0.000 claims description 18
- 238000002156 mixing Methods 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 108010001441 Phosphopeptides Proteins 0.000 claims description 14
- 229940071162 caseinate Drugs 0.000 claims description 14
- 244000293323 Cosmos caudatus Species 0.000 claims description 13
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 13
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000007968 orange flavor Substances 0.000 claims description 12
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 11
- 210000003022 colostrum Anatomy 0.000 claims description 11
- 235000021277 colostrum Nutrition 0.000 claims description 11
- 229960000306 zinc gluconate Drugs 0.000 claims description 11
- 239000011670 zinc gluconate Substances 0.000 claims description 11
- 235000011478 zinc gluconate Nutrition 0.000 claims description 11
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 10
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 10
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 10
- 239000000811 xylitol Substances 0.000 claims description 10
- 229960002675 xylitol Drugs 0.000 claims description 10
- 235000010447 xylitol Nutrition 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 241000209051 Saccharum Species 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 235000013402 health food Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 6
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- 230000006806 disease prevention Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical group [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 206010027439 Metal poisoning Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 208000008127 lead poisoning Diseases 0.000 description 2
- 230000001071 malnutrition Effects 0.000 description 2
- 235000000824 malnutrition Nutrition 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 208000015380 nutritional deficiency disease Diseases 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 206010037751 Radial nerve palsy Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- HUTDDBSSHVOYJR-UHFFFAOYSA-H bis[(2-oxo-1,3,2$l^{5},4$l^{2}-dioxaphosphaplumbetan-2-yl)oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O HUTDDBSSHVOYJR-UHFFFAOYSA-H 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- -1 polycalcium Chemical compound 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 208000009873 radial neuropathy Diseases 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Abstract
A Chewing tablet for removing lead from human body contains glutathion, VC, taurine, immune globulin and zinc. Its preparing process is also disclosed.
Description
Technical field
The present invention relates to a kind of health food and preparation method thereof, particularly a kind of chewing tablet for discharging lead preparation method.
Background technology
Along with industrial development, environmental pollution more and more is subjected to people's attention, and lead contamination more can not be ignored as " the stealthy killer " that threaten people's health, particularly children's torso health.
Plumbous main form with dust and smog in commercial production and the small stores enters human body by the respiratory tract and the suction road that disappears.Absorb comparatively fast nearly 20%～30% inspiration blood circulation through respiratory tract; Be about 5～10% through what digestive tract was exhaled receipts.Promptly enter liver behind the Plumbum absorption, a part is discharged to enteral by bile, and excrete with feces: another part enters blood.The plumbous initial stage is distributed in each tissue in the blood, and is the highest with Liver and kidney content, is deposited on bone and hair etc. with insoluble lead phosphate later on and locates.The acute lead poisoning clinical manifestation is gastrointestinal symptoms such as nauseating, vomiting, angina abdominis and constipation.In commercial production and the life mainly is chronic lead poisoning.Patient's early symptom is weak, in mouthful metallic taste is arranged, stomachache and neurasthenic syndrome then take place in muscle, joint aches, along with PD, motion can appear also and sensory nerve conduction velocity slows down, anemia, angina abdominis, wristdrop, urine protein and change in renal function etc.Lead is the unwanted trace element of a kind of human body, in human body without any physiological function.The too high easy initiation malnutrition of lead content in child's body, and malnutrition has further increased the weight of saturnine harm.The important upgrowth and development of children that hindered.Existing health food market lacks a kind of health food that can effectively promote human body Plumbum removing, extra-nutrition.
Summary of the invention
The technical problem to be solved in the present invention is how to fill up the blank of existing health food market, and a kind of chewing tablet for discharging lead and preparation method thereof is provided.
For solving the problems of the technologies described above, chewing tablet for discharging lead of the present invention contains glutathion, vitamin C, taurine, immunoglobulin, zinc.
Its special character is: it also comprises phosphopeptide caseinate and Margarita powder.
Its special character is: the weight proportion of above-mentioned component is that the weight proportion of above-mentioned component is a glutathion: 1-3 part, vitamin C: 4.00-11.97 part, taurine: 0.3-1 part, immunoglobulin: 4-10 part, zinc (in Zn): 0.15-0.5 part, phosphopeptide caseinate 1-2 part, Margarita powder: 20-30 part.
Its special character is: described immunoglobulin comes from cattle colostrums, described zinc comes from zinc gluconate.
Its special character is: it also comprises an amount of sweeting agent and edible essence.Adding sweeting agent and edible essence mainly is in order to improve the taste of invention chewing tablet for discharging lead.Its content can be adjusted to some extent, so that adjust its taste.
Its special character is: described sweeting agent comprises xylitol of 15-25 part and the white sugar of 12-20 part; Described edible essence is the orange flavor essence of 0.01-0.2 part.
Prepare the method for chewing tablet for discharging lead of the present invention, comprise the following steps:
A: the glutathion, the plain C of dimension master of 4.00-11.97 part, the phosphopeptide caseinate of 1-2 part, the 0.3-1 part cattle phosphoric acid that take by weighing 1-3 part, the Margarita powder of 20-30 part, contain 4-10 part immunoglobulin cattle colostrums powder and contain the zinc gluconate of the zinc of 0.15-0.5 part, mixed 20 minutes in high-speed mixer, it is fine powder A that abundant mixing is crossed 100 mesh sieves;
B: take by weighing xylitol, 12-20 part Saccharum Sinensis Roxb. of 15-25 part, the same mixing is crossed 100 mesh sieves and is got fine powder B;
C: the abundant mixing of fine powder A, B, put spray distilled water pelletize in the FL-type fluidized bed pelletizer, its control process parameters is as follows: 40 ℃ of air intakes, vibrate 4 times/minute, atomizing pressure 0.15MPA, hydrojet speed 56g/ minute, air door pressure 0.1MPA, auxiliary pneumatics 0.15MPA, when treating that grain forming is better, enter drying for the first time, inlet temperature is elevated to 50 ℃, vibrate 4 times/minute, air door pressure 0.2MPA, auxiliary pneumatics 10.15MPA, dry 25 minutes, when pellet moisture content is controlled at 1.5-2%, take out granule;
D: by 16 mesh sieve granulate, the granule of getting behind the part granulate sifts out fine powder C with 60 mesh sieves with the granule that makes, and by among the adding fine powder C, mixing is uniformly dispersed with 0.01-0.2 part orange flavor essence;
E: the granule behind the granulate is placed the V-type blender with the fine powder C that is added with orange flavor essence, and sealing was preserved 12 hours behind the mix homogeneously;
F: tabletting: the granule of the airtight preservation of mixing put 21 in the rotary tablet machine tabletting, the slice, thin piece that presses through sieve, detect qualified after, the packing warehouse-in.
Compound basis:
Glutathion: lead can combine with proteinic sulfydryl and organelle in cell; influence the generation of energy and suppress the transportation function that the ATP enzyme influences cell membrane by suppressing phosphorylation; thereby influence intravital oxidation-reduction system; reduce the Detoxication of body; the sulfydryl of glutathion can be with intravital lead and the complexation of SH group and lead is excreted; and by elimination free radical and other active metabolite, and protection cell and the infringement that alleviates plumbous pair cell.
Margarita powder, its main component is a calcium carbonate, calcium has identical approach and process with the absorption metabolism of lead, the physiological mechanism of some adjusting calcium metabolism is also influential to the absorption and the tissue metabolism of lead, EPDML result of study is consistent with experimental studies results, and calcium can suppress plumbous absorption, and promptly calcium deficiency can increase the absorption of intestinal to lead, replenish the calcium and can reduce the absorption of intestinal to lead, Pb-B and calcium intake are negative correlation.And intestinal causes the increase and the reduction of Pb-B to the increase of Plumbum absorption with reduce and can both be reflected on the Pb-B about one month time.Also contain several amino acids and trace element in the Margarita powder, can effectively improve the dietary protein nutritive value and replenish multiple element, help Plumbum removing.
Zinc gluconate is the supplement of zinc element, and zinc and lead are all bivalent metal ion, in gastrointestinal absorption and metabolic process, exists the effect of the antagonism of vying each other, and zinc supplement can reduce plumbous accumulating of tissue in vivo.
Plain C sequestration lead effectively in the dimension forms the lower Ascorbate of dissolubility, can reduce the absorption of body to lead on the one hand, can promote intravital lead to discharge from urine on the other hand.Vitamin C also is the very strong vitamin of a kind of reproducibility simultaneously, has multiple physiological function in vivo, and it can participate in the hydroxylation reaction and the reduction reaction of body, builds up resistance.
Taurine is a kind of sulfur-containing amino acid simple in structure; it is one of free amino acid the abundantest in the body; has the cell calcium of adjusting stable state; suppress biological effects such as lipid peroxidation; can promote child's brain intelligence to grow; can improve the absorption of zinc in the body to a certain extent, alleviate plumbous accumulating in brain.
Cattle colostrums powder is nutritious, and the wide spectrum antibody that it is contained and other immunity is because of in synergism, preventable disease, increase body resistance against diseases; Cattle colostrums powder plays omnibearing opsonic action, especially preventive effect by the control intestinal microbial population to human gastrointestinal tract function and even allomeric function.Has very high nutritive value.
Phosphopeptide caseinate can promote the absorption of bivalence such as calcium, ferrum from f, by replenishing calcium, ferrum, to promoting Plumbum removing, alleviates plumbous harm to hemopoietic function.
Xylitol is a kind of sweeting agent, gentle dose, can and make zymic growth and fermentation activity, but anti-caries.
Be rich in elements such as glutathion, polycalcium, ferrum, zinc in this chewing tablet for discharging lead, support one's family rope C, taurine and phosphopeptide caseinate by supplementing the nutrients, regulate metabolism, suppress plumbous absorption and increase plumbous discharge, and performance promotes the health care of Plumbum removing.
Chewing tablet for discharging lead of the present invention:
Carry out the food toxicological experiment through Capital University of Medical Sciences toxicological study chamber, do not find that any toxic and side effects (sees appended document: the Capital University of Medical Sciences-toxicology survey report);
Carry out zoopery through Nutrition and Food Safety Office of China Disease Prevention and control Centre, find that per os gave chewing tablet for discharging lead 30 days, plumbous content is compared with model control group in each dosage group rat serum, liver and the tibia all obvious reduction (P＜0.01) (sees appended document: Nutrition and Food Safety Office of China Disease Prevention and control Centre-zoopery survey report);
Carry out human experimentation through Nutrition and Food Safety Office of China Disease Prevention and control Centre, find that the Pb-B of test-meal group significantly is lower than matched group (P＜0.001); With compare before the experiment, test-meal group Pb-B significantly reduced (P＜0.001) when experiment finished; The lead in urine level of matched group and test-meal group does not have notable difference (P＞0.05) before the experiment; The 10th day, 20 days of experiment back test-meal group and 30 days lead in urine level are significantly higher than matched group (P＞0.05); With compare the lead in urine level of the 10th day, 20 days of experiment back test-meal group and 30 days significantly raise (P＞0.05) before the experiment; Always urine calcium and lead in urine are discharged the amplification (see appended document: Nutrition and Food Safety Office of China Disease Prevention and control Centre-human experiment experimental check is reported) that amplification is discharged less than total lead in urine.
According to promoting the lead-expelling function result to judge in " health food check and assessment technique standard-2003 year version ", chewing tablet for discharging lead of the present invention has the effect that promotes lead-expelling function.This chewing tablet for discharging lead has obtained State Food and Drug Administration's approval (see appended document: State Food and Drug Administration's health food is registered official written reply).
In sum: the inventor proposes a kind of unprecedented health food with promotion lead-expelling function and preparation method thereof.Chewing tablet for discharging lead of the present invention has having no side effect, promotes lead-expelling function obvious, and the advantage that taste is good is applicable to that the crowd who is subjected to lead contamination is edible.
Description of drawings
Fig. 1 is the technological process of production figure of chewing tablet for discharging lead of the present invention.
The specific embodiment
Below in conjunction with accompanying drawing chewing tablet for discharging lead of the present invention and preparation method thereof is described further:
Embodiment one: chewing tablet for discharging lead of the present invention comprises
Glutathion (purity is not less than 98%) 248g
Cattle colostrums powder (containing immunoglobulin 608 grams) 1520g
Margarita powder 2002g
The plain C 503g of dimension cattle
Zinc gluconate (containing zinc 26.24 grams) 202g
Phosphopeptide caseinate (purity is not less than 85%) 127g
Taurine 53g
Xylitol 1500g
White sugar 1365g
Orange flavor essence 1.284g
Every 0.75g of 7521.284g can be made into 10000 of qualified chewing tablet for discharging lead [eating method and amount] secondary every day altogether, and each two, the child reduces by half.
[storage method] seals, causes shady and cool dry place.
One, glutathion through Bioisystech Co., Ltd of HTC of section, meets subordinate list one requirement available from Beijing;
Two, Margarita powder meets the regulation of the Pharmacopoeia of the People's Republic of China 2000 editions;
Three, vitamin C meets Pharmacopoeia of People's Republic of China " 2000 editions regulation;
Four, zinc gluconate meets the regulation of the Pharmacopoeia of the People's Republic of China 2000 editions;
Five, phosphopeptide caseinate meets the requirement of table two available from Guangzhou Meichen Pharmaceutical Co., Ltd.;
Six, cattle phosphoric acid meets the requirement of GB14759-1993 food additive taurine:
Seven, xylitol meets the requirement of this essence of GB13509-1992 food additive alcohol;
Eight, cattle colostrums powder is driven perfume spring Food Co., Ltd available from Beijing pupil brightness, conforms to the requirement of table three;
Nine, orange flavor essence meets GB2760-1996 food accent and adds the requirement of agent use sanitary standard;
Ten, white sugar meets the requirement of GB 317-1998 white sugar.
Subordinate list one
| Project | Index |
| The outward appearance rerum natura | Milky or pale yellow powder, free from extraneous odour |
| Glutathione content % 〉= | 98 |
| Heavy metal (in Pb) mg/kg≤ | 20 |
| Moisture %≤ | 2 |
Subordinate list two
| Project | Index |
| The outward appearance rerum natura | Milky or pale yellow powder, free from extraneous odour |
| Phosphopeptide caseinate content (in butt) % 〉= | 85 |
| Heavy metal (in As) mg/kg≤ | 2 |
| Moisture %≤ | 10 |
Subordinate list three
| Project | Index |
| Moisture %≤ | 6 |
| Immunoglobulin % 〉= | 40 |
| Protein % 〉= | 40 |
| Total plate count (cfu/g)≤ | 1000 |
| Coliform (mpn/100g)≤ | 30 |
| Mycete (cfu/g)≤ | 25 |
| Yeast (cfu/g)≤ | 25 |
| Pathogenic bacterium (Salmonella. shigella, staphylococcus aureus. Hemolytic streptococcus) | Must not detect |
| Plumbous (in Pb) mg/kg≤ | 1.0 |
| Arsenic (with AS juice) mg/kg≤ | 0.5 |
As shown in Figure 1, the preparation method of chewing tablet for discharging lead of the present invention comprises the following steps:
A: take by weighing the glutathion (purity is not less than 98%) of 248 grams that meet the hygiology standard, the plain C of dimension master of 503 grams, the phosphopeptide caseinate (purity is not less than 85%), 53 of 127 grams respectively
GramCattle phosphoric acid, the cattle colostrums powder (immunoglobulin content is not less than 40%) of 2002 Margarita powder that restrain, 1520 grams and 202 gram zinc gluconate (zinc that contain 26.24 grams) mixed 20 minutes in high-speed mixer, and it is fine powder A that abundant mixing is crossed 100 mesh sieves;
B: take by weighing an amount of xylitol, the white sugar that meet the hygiology standard, the same mixing is crossed 100 mesh sieves and is got fine powder B;
C: the abundant mixing of fine powder A, B, put spray distilled water pelletize in the FL-5 type fluidized bed pelletizer, its control process parameters is as follows: 40 ℃ of air intakes, vibrate 4 times/minute, atomizing pressure 0.15MPA, hydrojet speed 56g/ minute, air door pressure 0.1MPA, auxiliary pneumatics 0.15MPA, when treating that grain forming is better, enter drying for the first time, inlet temperature is elevated to 50 ℃, vibrate 4 times/minute, air door pressure 0.2MPA, auxiliary pneumatics 10.15MPA, dry 25 minutes, when pellet moisture content is controlled at 1.5-2%, take out granule;
D: by 16 mesh sieve granulate, the granule of getting behind the part granulate sifts out an amount of fine powder C with 60 mesh sieves, and 1.284g orange flavor essence is pressed among the formula ratio adding fine powder C with the granule that makes, and mixing is uniformly dispersed;
E: the granule behind the granulate is placed the V-type blender with the fine powder C that is added with orange flavor essence, mixed 20 minutes, sampling is observed, and the color and luster uniformity stops to mix, and takes out granule, puts in all turning barrels, and sealing was preserved 12 hours.
F: tabletting: the granule of the airtight preservation of mixing put 21 in the rotary tablet machine tabletting, the slice, thin piece that presses sifts out fine powder, rejects substandard product, sampling Detection, qualified back packing, warehouse-in.
Embodiment two: chewing tablet for discharging lead of the present invention comprises
Glutathion (purity is not less than 98%) 102g
Cattle colostrums powder (containing immune globulin 400 grams) 1000g
Margarita powder 2000g
The plain C 400g of dimension cattle
Zinc gluconate (containing zinc 15 grams) 115.5g
Phosphopeptide caseinate (purity is not less than 85%) 117.65g
Taurine 30g
Xylitol 1500g
White sugar 1200g
Orange flavor essence 1g
The course of processing and points for attention are as described in the enforcement mode one.
Embodiment three: chewing tablet for discharging lead of the present invention comprises
Glutathion (purity is not less than 98%) 306g
Cattle colostrums powder (containing immunoglobulin 1000 grams) 2500g
Margarita powder 3000g
The plain C 1197g of dimension cattle
Zinc gluconate (containing zinc 50 grams) 384.91g
Phosphopeptide caseinate (purity is not less than 85%) 235.29g
Taurine 100g
Xylitol 2500g
White sugar 2000g
Orange flavor essence 5g
The course of processing and points for attention are as described in the enforcement mode one.
Embodiment four: chewing tablet for discharging lead of the present invention comprises
Glutathion (purity is not less than 98%) 2132.6g
Contain immunoglobulin 7340g
The plain C 6650g of dimension cattle
Zinc gluconate (containing the Zn348.9 gram) 2685.9g
Taurine 660g.
Claims (7)
1, a kind of chewing tablet for discharging lead contains glutathion, vitamin C, taurine, immunoglobulin, zinc.
2, chewing tablet for discharging lead according to claim 1 is characterized in that: it also comprises phosphopeptide caseinate and Margarita powder.
3, chewing tablet for discharging lead according to claim 2 is characterized in that: the weight proportion of above-mentioned component is a glutathion: 1-3 part, vitamin C: 4.00-11.97 part, taurine: 0.3-1 part, immunoglobulin: 4-10 part, zinc (in Zn): 0.15-0.5 part, phosphopeptide caseinate 1-2 part, Margarita powder: 20-30 part.
4, chewing tablet for discharging lead according to claim 3 is characterized in that: described immunoglobulin comes from cattle colostrums, described zinc comes from zinc gluconate.
5, chewing tablet for discharging lead according to claim 4 is characterized in that: it also comprises sweeting agent and edible essence.
6, chewing tablet for discharging lead according to claim 5 is characterized in that: described sweeting agent comprises xylitol of 15-25 part and the white sugar of 12-20 part; Described edible essence is the orange flavor essence of 0.01-0.2 part.
7, a kind of method for preparing the described chewing tablet for discharging lead of claim 6 comprises the following steps:
A: the glutathion, the plain C of dimension master of 4.00-11.97 part, the phosphopeptide caseinate of 1-2 part, the 0.3-1 part cattle phosphoric acid that take by weighing 1-3 part, the Margarita powder of 20-30 part, contain 4-10 part immunoglobulin cattle colostrums powder and contain the zinc gluconate of the zinc of 0.15-0.5 part, mixed 20 minutes in high-speed mixer, it is fine powder A that abundant mixing is crossed 100 mesh sieves;
B: take by weighing xylitol, 12-20 part Saccharum Sinensis Roxb. of 15-25 part, the same mixing is crossed 100 mesh sieves and is got fine powder B;
C: the abundant mixing of fine powder A, B, put spray distilled water pelletize in the FL-5 type fluidized bed pelletizer, its control process parameters is as follows: 40 ℃ of air intakes, vibrate 4 times/minute, atomizing pressure 0.15MPA, hydrojet speed 56g/ minute, air door pressure 0.1MPA, auxiliary pneumatics 0.15MPA, when treating that grain forming is better, enter drying for the first time, inlet temperature is elevated to 50 ℃, vibrate 4 times/minute, air door pressure 0.2MPA, auxiliary pneumatics 10.15MPA, dry 25 minutes, when pellet moisture content is controlled at 1.5-2%, take out granule;
D: by 16 mesh sieve granulate, the granule of getting behind the part granulate sifts out fine powder C with 60 mesh sieves with the granule that makes, and by among the adding fine powder C, mixing is uniformly dispersed with 0.01-0.2 part orange flavor essence;
E: the granule behind the granulate is placed the V-type blender with the fine powder C that is added with orange flavor essence, and sealing was preserved 12 hours behind the mix homogeneously;
F: tabletting: the granule of the airtight preservation of mixing put 21 in the rotary tablet machine tabletting, the slice, thin piece that presses through sieve, detect qualified after, the packing warehouse-in.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100350190A CN100490896C (en) | 2005-06-03 | 2005-06-03 | Lead-discharging chewable tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100350190A CN100490896C (en) | 2005-06-03 | 2005-06-03 | Lead-discharging chewable tablet and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1872338A true CN1872338A (en) | 2006-12-06 |
| CN100490896C CN100490896C (en) | 2009-05-27 |
Family
ID=37483046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100350190A Expired - Fee Related CN100490896C (en) | 2005-06-03 | 2005-06-03 | Lead-discharging chewable tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100490896C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103082003A (en) * | 2011-11-07 | 2013-05-08 | 上海奥医高科技实业有限公司 | Dietary supplement having immunoloregulation effect |
| CN103271340A (en) * | 2013-05-28 | 2013-09-04 | 天津商业大学 | Nanoscale health-care food capable of removing heavy metal in human body and preparation method thereof |
| CN103349673A (en) * | 2013-07-24 | 2013-10-16 | 绍兴文理学院 | Plumbum-expelling agent |
| CN103356719A (en) * | 2013-07-24 | 2013-10-23 | 绍兴文理学院 | Cadmium displacement agent |
| CN107006863A (en) * | 2017-04-13 | 2017-08-04 | 广东太阳神集团有限公司 | It is a kind of to promote health food of lead discharging and preparation method thereof |
| CN108065401A (en) * | 2016-11-11 | 2018-05-25 | 宋玉明 | A kind of growth chewable tablets |
-
2005
- 2005-06-03 CN CNB2005100350190A patent/CN100490896C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103082003A (en) * | 2011-11-07 | 2013-05-08 | 上海奥医高科技实业有限公司 | Dietary supplement having immunoloregulation effect |
| CN103271340A (en) * | 2013-05-28 | 2013-09-04 | 天津商业大学 | Nanoscale health-care food capable of removing heavy metal in human body and preparation method thereof |
| CN103349673A (en) * | 2013-07-24 | 2013-10-16 | 绍兴文理学院 | Plumbum-expelling agent |
| CN103356719A (en) * | 2013-07-24 | 2013-10-23 | 绍兴文理学院 | Cadmium displacement agent |
| CN103356719B (en) * | 2013-07-24 | 2016-06-29 | 绍兴文理学院 | A kind of cadmium displacement agent |
| CN108065401A (en) * | 2016-11-11 | 2018-05-25 | 宋玉明 | A kind of growth chewable tablets |
| CN107006863A (en) * | 2017-04-13 | 2017-08-04 | 广东太阳神集团有限公司 | It is a kind of to promote health food of lead discharging and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100490896C (en) | 2009-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3000100C (en) | Method of producing mushrooms | |
| CN1283171C (en) | Selenium-rich probiotics foder additive production method and its product | |
| CN102524540B (en) | Saving trace element compound packet as well as preparation method and application thereof | |
| CN102178699B (en) | Preparation for enhancing human immunity and promoting growth and development | |
| CN1333372A (en) | Process for preparing potide zinc easy absorbed in human body | |
| CN105999231A (en) | Polypeptide composition, composition for improving livestock and poultry immune function, and preparation method of composition for improving livestock and poultry immune function | |
| CN105918607A (en) | Soybean whey protein composite powder and preparation method thereof | |
| CN1872338A (en) | Chewing tablet for discharging lead, and preparation method | |
| CN100344326C (en) | Iron-supplementing preparation | |
| CN1339317A (en) | Poria oral liquor and its producing method | |
| CN106858610A (en) | The preparation method of a kind of amino acid chelated calcium and including the chelated calcium calcium-supplementing preparation | |
| CN1895066A (en) | Anti-body leben tablet (powder) | |
| KR100585970B1 (en) | Duck breeding method using pine needles and garlic and its duck meat | |
| CN113057261A (en) | Acid preparation composition for improving production performance of meat pigeons, preparation method and application | |
| CN1168498C (en) | Children's Xuebao chewable tablet and preparation method thereof | |
| CN1813794A (en) | Lead-removing growth-assisting tablet and its preparing method | |
| CN1846514A (en) | Selenium protein milk tablet | |
| CN107535717B (en) | It is a kind of to be used to treat solid feed of rabbit diarrheb and preparation method thereof | |
| KR102699079B1 (en) | Nanoproducts containing vitamins a, d3 and e, and nutritional supplements for animals using the same | |
| CN1282476C (en) | A preparation for regulating lower intestinal function | |
| CN1203878C (en) | Organic state micro element supplement agent | |
| CN1112214C (en) | Organic trace element replenisher | |
| CN1171594C (en) | Composition containing pearl powder and ascorbic acid | |
| CN100502672C (en) | A kind of milk for regulating body immunity and preparation method thereof | |
| CN106074798A (en) | A kind of dog chewable tablet and preparation method thereof of replenishing the calcium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181016 Address after: 519000 No. 8, science and technology two road, Harbour Road, Tangjia Bay, Zhuhai, Guangdong Patentee after: ZHUHAI NATURAL PHARMACEUTICAL INSTITUTE Ltd. Address before: 519000 No. 8, science and technology two road, Harbour Road, Tangjia Bay, Zhuhai, Guangdong Patentee before: Yan Yusen |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090527 |